FFA
EDIT icon

Farther Finance Advisors’s Editas Medicine EDIT Stock Holding History

Farther Finance Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11K Sell
653
-1,002
-61% -$2.93K ﹤0.01% 5153
2026
Q1 		$4.32K Buy
1,655
+517
+45% +$1.09K ﹤0.01% 4566
2025
Q4 		$2.33K Hold
1,138
– – ﹤0.01% 4633
2025
Q3 		$3.95K Buy
+1,138
New +$3.18K ﹤0.01% 3866
2025
Q2 		– Sell
-106
Closed -$120 – 4539
2025
Q1 		$120 Sell
106
-120
-53% -$177 ﹤0.01% 4045
2024
Q4 		$287 Buy
+226
New +$576 ﹤0.01% 3567
2024
Q3 		– Sell
-10
Closed -$46 – 4037
2024
Q2 		$46 Hold
10
– – ﹤0.01% 3699
2024
Q1 		$73 Sell
10
-1
-9% -$8 ﹤0.01% 3421
2023
Q4 		$111 Buy
+11
New +$97 ﹤0.01% 3290

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Farther Finance Advisors's EDIT Position: Q2 2026 in Review

Farther Finance Advisors reduced its Editas Medicine (EDIT) stake by 61% in Q2 2026, selling an estimated $2.93K and leaving 653 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #5153.

Farther Finance Advisors first reported a position in EDIT in Q4 2023 and has held it in 9 quarters since. The position peaked at $4.32K in Q1 2026. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Farther Finance Advisors held 653 shares of Editas Medicine worth $2.11K as of Q2 2026.
  • Farther Finance Advisors sold 1,002 Editas Medicine shares in Q2 2026, an estimated $2.93K.
  • Editas Medicine made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5153 holding.
  • Farther Finance Advisors first reported a position in Editas Medicine in Q4 2023 and has held it in 9 quarters since.
  • Farther Finance Advisors's Editas Medicine position peaked at $4.32K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.